Cytology-based Circulating Tumour Cell (CTC) Testing in cancer patients and for early detection screening: The ISET-CTC study
Not Applicable
Recruiting
- Conditions
- cancerinfectionCancer - Any cancerInfection - Studies of infection and infectious agents
- Registration Number
- ACTRN12620000986976
- Lead Sponsor
- AProf Dr Karin Ried
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria
Group 1: Cancer patients
a) have previously received (at least 3 weeks ago) or will receive treatment within one week; treatment may include chemotherapy, radiotherapy, hyperthermia, intravenous Vit C, IV Curcumin, or other complementary treatment as prescribed by the treating physician
b) for regular monitoring . detection of relapse or tumour progression
Group 2: Early detection screening: Patients with a family history of cancer of patients with a chronic disease, advanced age, or as part of a health check
Exclusion Criteria
no exclusion
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method